Olink Holding AB (publ) (NASDAQ:OLK) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Olink Holding AB (publ) (NASDAQ:OLKGet Free Report) posted its earnings results on Monday. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.01), Zacks reports. Olink Holding AB (publ) had a negative net margin of 19.72% and a negative return on equity of 7.00%. The business had revenue of $28.75 million for the quarter, compared to analysts’ expectations of $31.29 million.

Olink Holding AB (publ) Price Performance

Shares of NASDAQ:OLK traded up $0.29 during trading on Wednesday, reaching $24.01. 692,580 shares of the company’s stock traded hands, compared to its average volume of 609,011. Olink Holding AB has a 12 month low of $14.10 and a 12 month high of $26.01. The stock has a market capitalization of $2.99 billion, a P/E ratio of -87.85 and a beta of 0.50. The company has a 50 day moving average of $23.31 and a 200-day moving average of $24.32.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Morgan Stanley reissued an “equal weight” rating and issued a $26.00 price objective on shares of Olink Holding AB (publ) in a research report on Tuesday, March 26th. Canaccord Genuity Group restated a “hold” rating and issued a $26.00 price target on shares of Olink Holding AB (publ) in a report on Tuesday, March 26th.

Get Our Latest Analysis on OLK

About Olink Holding AB (publ)

(Get Free Report)

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.

Featured Stories

Earnings History for Olink Holding AB (publ) (NASDAQ:OLK)

Receive News & Ratings for Olink Holding AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olink Holding AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.